Skip to main content
. 2019 Dec 7;22(5):705–717. doi: 10.1093/neuonc/noz232

Fig. 1.

Fig. 1

VB-111 dual mechanism of action: (1) Targeting tumor vasculature by apoptosis of angiogenic endothelial cells. (2) Induction of an antitumor immune response.